Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Encouraging safety and efficacy for REGN5459, a BCMA×CD3 bispecific antibody with low CD3 affinity, in patients with RRMM

Dr Attaya Suvannasankha - Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, USA
Encouraging safety and efficacy for REGN5459, a BCMA×CD3 bispecific antibody with low CD3 affinity, in patients with RRMM ( Dr Attaya Suvannasankha - Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, USA )
20 Apr 2023

Cancer Care in Older Adults and Special Population

Dr Don Dizon - Rhode Island Hospital, Rhode Island, USA
Cancer Care in Older Adults and Special Population ( Dr Don Dizon - Rhode Island Hospital, Rhode Island, USA )
20 Apr 2023

The clinical impact of the Choosing Wisely project

Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines
The clinical impact of the Choosing Wisely project ( Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines )
20 Apr 2023

Why tumour markers are not recommended as screening tests

Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines
Why tumour markers are not recommended as screening tests ( Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines )
20 Apr 2023

ALLO-316 demonstrates encouraging anti-tumour activity for patients with advanced or metastatic ccRCC

Dr Samer Srour - The University of Texas MD Anderson Cancer Center, Houston, USA
ALLO-316 demonstrates encouraging anti-tumour activity for patients with advanced or metastatic ccRCC ( Dr Samer Srour - The University of Texas MD Anderson Cancer Center, Houston, USA )
20 Apr 2023

Applying the syndemic framework to cancer research for effective cancer control in LMICs

Dr Mariam Hassan - Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
Applying the syndemic framework to cancer research for effective cancer control in LMICs ( Dr Mariam Hassan - Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan )
20 Apr 2023

Addition of Salmonella-IL2 to FOLFIRINOX for metastatic stage 4 pancreatic cancer nearly doubles median survival

Prof Daniel Saltzman - University of Minnesota, Minneapolis, USA
Addition of Salmonella-IL2 to FOLFIRINOX for metastatic stage 4 pancreatic cancer nearly doubles median survival ( Prof Daniel Saltzman - University of Minnesota, Minneapolis, USA )
20 Apr 2023

Atezo plus bev demonstrates efficacy in preventing recurrence in patients with high-risk HCC

Prof Pierce Chow - Duke-NUS Medical School, Singapore
Atezo plus bev demonstrates efficacy in preventing recurrence in patients with high-risk HCC ( Prof Pierce Chow - Duke-NUS Medical School, Singapore )
20 Apr 2023

A single fractionated cycle of 225Ac-J591 shows preliminary efficacy on mCRPC patients

Dr Jones Nauseef - Weill Cornell Medicine, New York City, USA
A single fractionated cycle of 225Ac-J591 shows preliminary efficacy on mCRPC patients ( Dr Jones Nauseef - Weill Cornell Medicine, New York City, USA )
20 Apr 2023

IO-108 shows promising results in the treatment of advanced relapsed or refractory solid tumours

Dr Matthew Taylor - Providence Cancer Institute, Portland, USA
IO-108 shows promising results in the treatment of advanced relapsed or refractory solid tumours ( Dr Matthew Taylor - Providence Cancer Institute, Portland, USA )
20 Apr 2023

Higher BMI may be linked with worse survival among SBS88 positive CRC patients

Dr Claire Thomas - Fred Hutchinson Cancer Center, Seattle, USA
Higher BMI may be linked with worse survival among SBS88 positive CRC patients ( Dr Claire Thomas - Fred Hutchinson Cancer Center, Seattle, USA )
20 Apr 2023

MatchMiner: An open-source AI precision medicine trial matching platform

Dr Harry Klein - Dana Farber Cancer Institute, Boston, USA
MatchMiner: An open-source AI precision medicine trial matching platform ( Dr Harry Klein - Dana Farber Cancer Institute, Boston, USA )
20 Apr 2023